WAM
ICCM icon

Warberg Asset Management’s IceCure Medical ICCM Stock Holding History

Warberg Asset Management’s Portfolio ICCM Stock Details ICCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,186
Closed -$19.7K – 185
2026
Q1 		$19.7K Buy
+2,186
New +$39.9K ﹤0.01% 159

Other funds holding ICCM

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GCM
Gunderson Capital Management Mt. Pleasant, South Carolina $370M AUM 211.56% 1-Year Est. Return
KFG
Kingdom Financial Group Peoria, Arizona $391M AUM 21.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Warberg Asset Management's ICCM Position: Q2 2026 in Review

Warberg Asset Management sold out of IceCure Medical (ICCM) in Q2 2026, closing a stake of 2,186 shares — an estimated $19.7K sold.

Warberg Asset Management first reported a position in ICCM in Q1 2026 and held it in 1 quarter. The position peaked at $19.7K in Q1 2026. 11 funds tracked by Wall St. Rank hold ICCM as of Q2 2026.

  • Warberg Asset Management reported no remaining IceCure Medical position as of Q2 2026 after selling out during the quarter.
  • Warberg Asset Management sold 2,186 IceCure Medical shares in Q2 2026, an estimated $19.7K.
  • Warberg Asset Management first reported a position in IceCure Medical in Q1 2026 and held it in 1 quarter.
  • Warberg Asset Management's IceCure Medical position peaked at $19.7K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held IceCure Medical as of Q2 2026.

Based on Warberg Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.